Latest News and Press Releases
Want to stay updated on the latest news?
-
GLP-1 medications drove 13% of non-surgical aesthetic spend in 2024, reshaping the $19.2B industry as medspas see rising revenue and younger patients.
-
Medical aesthetics non-surgical revenues rose 9% in H1 2024, driven by semaglutides, neurotoxins, and a growing consumer base, per Guidepoint & Skytale.